Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

New Haven, Connecticut 06511


Purpose:

The purpose of this study is to demonstrate bioequivalence of single doses of two verapamil formulations


Criteria:

Inclusion Criteria: - Healthy male and/or female subjects - Mass Index (BMI) of approximately 18 to 30 kg/m2 Exclusion Criteria: - Any condition possibly affecting drug absorption - A positive urine drug screen


NCT ID:

NCT00668967


Primary Contact:

Study Director
Pfizer CT.gov Call Center
Pfizer


Backup Contact:

N/A


Location Contact:

New Haven, Connecticut 06511
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.